New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII

Meleddu R.;Distinto S.;Cottiglia F.;Angius R.;Caboni P.;Deplano S.;Maccioni E.
2020-01-01

Abstract

In the present study we investigated the structure-activity relationships of a new series of 4-[(3-ethyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides (EMAC10101a-m). All synthesized compounds, with the exception of compound EMAC10101k, preferentially inhibit off-target hCA II isoform. Within the series, compound EMAC10101d, bearing a 2,4-dichorophenyl substituent in position 4 of the dihydrothiazole ring, was the most potent and selective toward hCA II with an inhibitory activity in the low nanomolar range.
2020
Anticancer agents; Benzensulfonamides; Carbonic anhydrase; Docking; Dual enzyme inhibitors
Files in This Item:
File Size Format  
ACS-2020.pdf

open access

Type: versione editoriale
Size 1.99 MB
Format Adobe PDF
1.99 MB Adobe PDF View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie